Characteristics of Faecal Microbiota in Paediatric Crohn’s Disease and Their Dynamic Changes During Infliximab Therapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Crohn's & Colitis

• Publication date

  2018-02-28

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/ecco-jcc/jjx153PMID 29194468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A microbial signature for Crohn's disease

  2017cited by this paper
• Epidemiology of inflammatory bowel diseases from west to east

  2017cited by this paper
• Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

  2017cited by this paper
• Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.

  2016cited by this paper
• Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection

  2016cited by this paper
• The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response

  2016cited by this paper
• Genetics and Pathogenesis of Inflammatory Bowel Disease.

  2016cited by this paper
• Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn's disease

  2016cited by this paper
• KEGG: new perspectives on genomes, pathways, diseases and drugs

  2016cited by this paper
• Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease

  2016cited by this paper
• Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

  2015cited by this paper
• Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis

  2015cited by this paper
• The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects

  2015cited by this paper
• Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.

  2015cited by this paper
• Treatment of IBD: Where We Are and Where We Are Going

  2015cited by this paper
• Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohn's Disease

  2014cited by this paper
• Conference on ‘ Diet , gut microbiology and human health ’ Symposium 3 : Diet and gut metabolism : linking microbiota to bene fi cial products of fermentation Links between diet , gut microbiota composition and gut metabolism

  2014cited by this paper
• Meta‐analyses of human gut microbes associated with obesity and IBD

  2014cited by this paper
• Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

  2014cited by this paper
• The gut microbiota and inflammatory bowel disease

  2014cited by this paper
• The treatment-naive microbiome in new-onset Crohn's disease.

  2014cited by this paper
• Advances in the medical management of paediatric IBD

  2014cited by this paper
• A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

  2013cited by this paper
• ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

  2013cited by this paper
• Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease.

  2013cited by this paper
• The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

  2013cited by this paper
• TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

  2013cited by this paper
• Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation

  2013cited by this paper
• The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

  2013cited by this paper
• Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

  2013cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats

  2012cited by this paper
• Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease

  2012cited by this paper
• Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

  2012cited by this paper
• The gut microbiota in IBD

  2012cited by this paper
• Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation.

  2011cited by this paper
• Metagenomic biomarker discovery and explanation

  2011cited by this paper
• Genetics and pathogenesis of inflammatory bowel disease

  2011cited by this paper
• Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease

  2011cited by this paper
• Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray

  2010cited by this paper
• Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.

  2010cited by this paper
• Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.

  2009cited by this paper
• The ecology, epidemiology and virulence of Enterococcus.

  2009cited by this paper
• Low counts of Faecalibacterium prausnitzii in colitis microbiota

  2009cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

  2007cited by this paper
• Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

  2007cited by this paper
• Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

  2007cited by this paper
• Diagnostics of inflammatory bowel disease.

  2007cited by this paper
• Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces.

  2006cited by this paper
• Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

  2005cited by this paper
• Lactate-Utilizing Bacteria, Isolated from Human Feces, That Produce Butyrate as a Major Fermentation Product

  2004cited by this paper
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

  2002cited by this paper
• Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice.

  2002cited by this paper
• Maintenance infliximab for Crohn's disease.

  2002cited by this paper
• Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut

  2000cited by this paper

• A validation for sex differences in gut microbiome of essential hypertension based on cohort analysis.

  2026cites this paper
• Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

  2026cites this paper
• Gut Microbiota Alterations and Dysbiosis Patterns in Pediatric Inflammatory Bowel Disease: Clinical Correlations and Therapeutic Impact.

  2026cites this paper
• Comparing Disease Severity Before and After Infliximab Treatment in Children with Inflammatory Bowel Disease (2015 - 2020) at a Tertiary Center

  2026cites this paper
• Gut microbiota as a potential predictor of therapeutic response in adults with Crohn’s disease: A systematic review

  2025cites this paper
• Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review

  2025cites this paper
• Individual-network based predictions of microbial interaction signatures for response to biological therapies in IBD patients

  2025influential citation
• Odoribacter splanchnicus-derived extracellular vesicles alleviate inflammatory bowel disease by modulating gastrointestinal inflammation and intestinal barrier function via the NLRP3 inflammasome suppression

  2025cites this paper
• Fecal microbiota and genetics in pediatric-onset orofacial granulomatosis and Crohn´s disease

  2025influential citation
• Microbiota regulated by Shenling Baizhu powder maintains intestinal homeostasis via the gut-breast axis.

  2025cites this paper
• Genistein alleviates colitis by suppressing inflammation and modulating colonic Marvinbryantia formatexigens abundance and metabolites

  2025cites this paper
• Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD)

  2025influential citation
• Gut microbiome predictors of advanced therapy response in Crohn’s disease: protocol for the OPTIMIST prospective, longitudinal, observational pilot study in Canada

  2025cites this paper
• Microbiota modulation and microbial metabolites produced during the in vitro colonic fermentation of Psidium guajava species.

  2025cites this paper
• Odoribacter splanchnicus—A Next-Generation Probiotic Candidate

  2025cites this paper
• Incorporating scale uncertainty in microbiome and gene expression analysis as an extension of normalization

  2025cites this paper
• Fecal Microbial Community Profiling Allows Discrimination of Phenotype and Treatment Response in Pediatric Crohn’s Disease and Ulcerative Colitis—An International Meta-Analysis

  2025cites this paper
• The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab

  2025cites this paper
• Age-related Eye Disease Studies Supplements and Genetic Risk Score Are Crucial Determinants of Intestinal Microbial Alterations in Advanced Age-Related Macular Degeneration

  2025cites this paper
• Sea buckthorn bioactive metabolites and their pharmacological potential in digestive diseases

  2025cites this paper
• Comparative Study of In Vitro Colonic Fermentation Dynamics: Human Gut Microbiota Response to Resistant Starch Derived from Germinated and Extruded Pea Seeds

  2025cites this paper
• A systematic longitudinal study of microbiome: integrating temporal-spatial dimensions with causal and deep learning models

  2025cites this paper
• Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review.

  2024cites this paper
• Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease

  2024cites this paper
• Intestinal metabolites predict treatment resistance of patients with depression and anxiety

  2024cites this paper
• Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis

  2024cites this paper
• Evaluation of microbiome composition combined with serum untargeted metabolomic profiling in newly diagnosed children with inflammatory bowel disease

  2024cites this paper
• Effects of dietary rosemary ultrafine powder supplementation on aged hen health and productivity: a randomized controlled trial

  2024cites this paper
• Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation

  2024cites this paper
• Causal effects between gut microbiota and endometriosis: a two-sample Mendelian randomisation study

  2024cites this paper
• Sanguinarine chloride hydrate mitigates colitis symptoms in mice through the regulation of the intestinal microbiome and metabolism of short-chain fatty acids.

  2024cites this paper
• Optimization of a gelatin/carboxymethylcellulose-based probiotic microcapsule and its application in preventing dextran sodium sulfate-induced colitis in mice.

  2024cites this paper
• Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients

  2024cites this paper
• Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease

  2024cites this paper
• Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy

  2024cites this paper
• Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

  2024cites this paper
• Persistent dysbiosis of duodenal microbiota in patients with controlled pediatric Crohn’s disease after resolution of inflammation

  2024cites this paper
• Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis.

  2024cites this paper
• Macleaya cordata extract exhibits some potential as a surrogate antibiotic by improving gastrointestinal epithelial status and humoral response in goats

  2024cites this paper
• Prevalence of Sutterella wadsworthensis in the fecal microbiota of obese children

  2024cites this paper
• Physiochemical characterization and ameliorative effect of rice resistant starch modified by heat-stable α-amylase and glucoamylase on the gut microbial community in T2DM mice.

  2024cites this paper
• Sea Buckthorn Polysaccharide Ameliorates Colitis

  2024cites this paper
• Probiotic properties and the ameliorative effect on DSS-induced colitis of human milk-derived Lactobacillus gasseri SHMB 0001.

  2024cites this paper
• Beyond Normalization: Incorporating Scale Uncertainty in Microbiome and Gene Expression Analysis

  2024cites this paper
• Disease Prediction From Human Microbiome by Utilizing Machine Learning

  2024cites this paper
• Social isolation induces intestinal barrier disorder and imbalances gut microbiota in mice.

  2024cites this paper
• Synergistic impact of Gui Zhi Shao Yao Zhi Mu Decoction and leflunomide on gut microbiota in rheumatoid arthritis: insights from 16S rDNA sequencing.

  2024cites this paper
• Compositional and functional alteration of gut microbiota profiles in response to anti-TNF-α therapy in inflammatory bowel disease: A Pilot study

  2023cites this paper
• Long-term effects on liver metabolism induced by ceftriaxone sodium pretreatment.

  2023cites this paper
• Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review

  2023influential citation
• Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

  2023cites this paper
• Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer

  2023cites this paper
• Hesteetako hanturazko gaixotasuna: patogenia, tratamenduak eta mikrobiotan oinarritutako biomarkatzaileak

  2023cites this paper
• Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter

  2023cites this paper
• Fecal microbiota related to postoperative endoscopic recurrence in patients with Crohn's disease

  2023cites this paper
• Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review

  2023cites this paper
• Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches

  2023cites this paper
• A polysaccharide from yogurt fermented by Lactobacillus bulgaricus and Streptococcus thermophilus: Structural characteristics and its alleviative effect on DSS-induced colitis in mice

  2023cites this paper
• Intestinal Microecology in Pediatric Surgery-Related Gastrointestinal Diseases: Current Insights and Future Perspectives

  2023cites this paper
• Faecal Bacteriome and Metabolome Profiles Associated with Decreased Mucosal Inflammatory Activity Upon Anti-TNF Therapy in Paediatric Crohn’s Disease

  2023cites this paper
• Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions

  2022cites this paper
• Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities

  2022cites this paper
• Dietary Oxidized Cholesterol Aggravates Chemically Induced Murine Colon Inflammation and Alters Gut Microbial Ecology.

  2022cites this paper
• Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.

  2022cites this paper
• Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment

  2022cites this paper
• Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease

  2022cites this paper
• Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease

  2022cites this paper
• Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism

  2022influential citation
• Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases

  2022cites this paper
• A Pilot Study Investigating Faecal Microbiota After Two Dietary Interventions in Children with Juvenile Idiopathic Arthritis

  2022cites this paper
• Hesteetako hanturazko gaixotasuna: patogenia, tratamenduak eta mikrobiotan oinarritutako biomarkatzaileak

  2022cites this paper
• Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice

  2022cites this paper
• Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases

  2022cites this paper
• Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis

  2022cites this paper
• The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α

  2022cites this paper
• Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy

  2022cites this paper
• Orally Administered Diosgenin Alleviates Colitis in Mice Induced by Dextran Sulfate Sodium through Gut Microbiota Modulation and Short-Chain Fatty Acid Generation

  2022cites this paper
• "EFFECT OF DIETARY PROBIOTICS ON INTESTINAL MICROBIOTA IN PATIENTS WITH CROHN’S DISEASE"

  2022cites this paper
• A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.

  2022cites this paper
• Dietary lactate supplementation can alleviate DSS-induced colitis in piglets.

  2022cites this paper
• TRANS-OMIC KNOWLEDGE TRANSFER MODELING INFERS GUT MICROBIOME BIOMARKERS OF ANTI-TNF RESISTANCE IN ULCERATIVE COLITIS.

  2022cites this paper
• Intestinal Inflammation and Parkinson’s Disease

  2021cites this paper
• Prevention and Alleviation of Dextran Sulfate Sodium Salt-Induced Inflammatory Bowel Disease in Mice With Bacillus subtilis-Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal Flora

  2021cites this paper
• Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease

  2021cites this paper
• The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?

  2021cites this paper
• Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review

  2021cites this paper
• Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases

  2021cites this paper
• Gut dysbiosis during early life: causes, health outcomes, and amelioration via dietary intervention

  2021cites this paper
• Paediatric IBD: the host, diet & microbes in pathogenesis & treatment: a narrative review

  2021influential citation
• Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis

  2021cites this paper
• Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment

  2021cites this paper
• Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination

  2021cites this paper
• Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF

  2021cites this paper
• Interrelationship between the 5-Lipoxygenase pathway and microbial Dysbiosis in the progression of Alzheimer's disease.

  2021cites this paper
• Changes in the gut microbiome associated with infliximab in patients with bipolar disorder

  2021cites this paper
• Inflammatory bowel disease and the gut microbiota

  2021cites this paper
• Lactobacillus ruminis Alleviates DSS-Induced Colitis by Inflammatory Cytokines and Gut Microbiota Modulation

  2021cites this paper
• Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn’s Disease

  2021cites this paper
• Gut microbiome is associated with multiple sclerosis activity in children

  2021cites this paper
• Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis

  2021cites this paper